Literature DB >> 20635073

[Neurological complications of neurooncological therapy].

U Herrlinger1, J P Steinbach.   

Abstract

Neurological complications of therapeutic procedures for brain tumors are increasingly being recognized. These encompass the classic types of central and peripheral neurotoxicity, such as radiotherapy-induced leukoencephalopathy and platinum-induced neuropathy. However, the advent of novel protocols and targeted therapeutics has expanded the spectrum of neurological complications. A problem of considerable importance is pseudoprogression after radiochemotherapy with temozolomide. Among the new targeted drugs complications of therapy with bevacizumab are the subject of intense discussion. In this review article the neurotoxic potential of intrathecal chemotherapy, kinase inhibitors, immunological strategies and local therapies are summarized. Knowledge about neurological complications of brain tumor therapy procedures is important for risk assessment and patient information.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20635073     DOI: 10.1007/s00115-010-2958-z

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  70 in total

1.  Treatment of ifosfamide encephalopathy with intravenous thiamin.

Authors:  José M Buesa; Paula García-Teijido; Raquel Losa; Joaquín Fra
Journal:  Clin Cancer Res       Date:  2003-10-01       Impact factor: 12.531

2.  Treatment of cerebral radionecrosis by hyperbaric oxygen therapy.

Authors:  K A Leber; H G Eder; H Kovac; U Anegg; G Pendl
Journal:  Stereotact Funct Neurosurg       Date:  1998-10       Impact factor: 1.875

3.  Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study.

Authors:  M Klein; J J Heimans; N K Aaronson; H M van der Ploeg; J Grit; M Muller; T J Postma; J J Mooij; R H Boerman; G N Beute; G J Ossenkoppele; G W van Imhoff; A W Dekker; J Jolles; B J Slotman; H Struikmans; M J B Taphoorn
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

4.  Primary central nervous system lymphoma 1991-1997: outcome and late adverse effects after combined modality treatment.

Authors:  U Herrlinger; M Schabet; W Brugger; R D Kortmann; L Kanz; M Bamberg; J Dichgans; M Weller
Journal:  Cancer       Date:  2001-01-01       Impact factor: 6.860

5.  Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma.

Authors:  Annika Juergens; Hendrik Pels; Sabine Rogowski; Klaus Fliessbach; Axel Glasmacher; Andreas Engert; Marcel Reiser; Volker Diehl; Marlies Vogt-Schaden; Gerlinde Egerer; Gabriele Schackert; Heinz Reichmann; Frank Kroschinsky; Udo Bode; Ulrich Herrlinger; Michael Linnebank; Martina Deckert; Rolf Fimmers; Ingo G H Schmidt-Wolf; Uwe Schlegel
Journal:  Ann Neurol       Date:  2010-02       Impact factor: 10.422

6.  Myelopathy due to intrathecal chemotherapy: report of six cases.

Authors:  Ali Bay; Ahmet Faik Oner; Omer Etlik; Cahide Yilmaz; Huseyin Caksen
Journal:  J Pediatr Hematol Oncol       Date:  2005-05       Impact factor: 1.289

7.  Treatment of radiation-induced nervous system injury with heparin and warfarin.

Authors:  M J Glantz; P C Burger; A H Friedman; R A Radtke; E W Massey; S C Schold
Journal:  Neurology       Date:  1994-11       Impact factor: 9.910

8.  Steroid-induced weakness in patients with primary brain tumors.

Authors:  E J Dropcho; S J Soong
Journal:  Neurology       Date:  1991-08       Impact factor: 9.910

9.  White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02).

Authors:  B W Corn; D M Yousem; C B Scott; M Rotman; S O Asbell; D F Nelson; L Martin; W J Curran
Journal:  Cancer       Date:  1994-11-15       Impact factor: 6.860

10.  Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab.

Authors:  Eudocia C Quant; Andrew D Norden; Jan Drappatz; Alona Muzikansky; Lisa Doherty; Debra Lafrankie; Abigail Ciampa; Santosh Kesari; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2009-03-30       Impact factor: 12.300

View more
  1 in total

Review 1.  [Visualization of radiation effects on the central nervous system].

Authors:  M Essig; J Dinkel; C Zamecnik
Journal:  Radiologe       Date:  2012-03       Impact factor: 0.635

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.